Table 2.
Clinical features of penicilliosis marneffei among patients with and without HIV infection
| Variables | HIV-infected patients (N = 116) | HIV-uninfected patients (N = 34) | p-values |
|---|---|---|---|
| Fever |
101 (87.1%) |
22 (64.7%) |
0.005 |
| Lymphadenopathy |
37 (31.9%) |
13 (38.2%) |
0.537 |
| Hepatomegaly |
42 (36.2%) |
6 (17.6%) |
0.059 |
| Splenomegaly |
25 (21.6%) |
2 (5.9%) |
0.042 |
| Cutaneous lesions |
47 (40.5%) |
14 (41.2%) |
1.000 |
| Umbilicated lesions |
45 (95.7%) |
5 (35.7%) |
|
| Sweet’s syndrome |
0 |
5 (35.7%) |
|
| Pustular psoriasis |
1 (2.1%) |
1 (7.1%) |
|
| Chronic ulcer |
1 (2.1) |
0 |
|
| Subcutaneous nodule |
0 |
1 (7.1%) |
|
| Subcutaneous abscess |
0 |
1 (7.1%) |
|
| Panniculitis |
0 |
1 (7.1%) |
|
| Cough |
32 (27.6%) |
8 (23.5%) |
0.826 |
| Anemia |
8 (6.9%) |
0 |
0.199 |
| Diarrhea |
15 (12.9%) |
2 (5.9%) |
0.362 |
| Arthritis/osteomyelitis |
0 |
5 (14.7%) |
<0.001 |
| Duration of symptoms (days) (Median, IQR) | 30 (14, 30) | 30 (14, 60) | 0.061 |